Company Profiles

driven by the PitchBook Platform

Milestone Pharmaceuticals

Description

Developer of cardiovascular drugs intended to meet the growing medical need related to safety of the cardiac procedure. The company's cardiovascular drug is a potent, self-delivered and short-acting nasally-delivered calcium channel antagonist for the episodic treatment of paroxysmal supraventricular tachycardia (PSVT), a cardiac arrhythmia, enabling patients to treat episodes at home and improve their quality of life.

2005

Founded

PRIVATE

Status

Later Stage VC

Latest Deal Type

$34M

Total Amount Raised

7

Investors

Description

Developer of cardiovascular drugs intended to meet the growing medical need related to safety of the cardiac procedure. The company's cardiovascular drug is a potent, self-delivered and short-acting nasally-delivered calcium channel antagonist for the episodic treatment of paroxysmal supraventricular tachycardia (PSVT), a cardiac arrhythmia, enabling patients to treat episodes at home and improve their quality of life.

Website:

www.milestonepharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

1111 Drive, Frederik-Philips Boulevard Suite 420 Saint-Laurent, Quebec H4M 2X6Canada +1 (514) 336-0444
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Milestone Pharmaceuticals's full profile, request a free trial.

Milestone Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Milestone Pharmaceuticals Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BDC Healthcare Venture FundVenture CapitalMinority000 0000000 0000
Domain AssociatesVenture CapitalMinority000 0000000 0000
Fonds Bio-InnovationOtherMinority000 0000000 0000
Fonds de solidarité FTQVenture CapitalMinority000 0000000 0000
GO Capital (France)Venture CapitalMinority000 0000000 0000
BDC Healthcare Venture Fund Venture Capital
Domain Associates Venture Capital
Fonds Bio-Innovation Other
Fonds de solidarité FTQ Venture Capital
GO Capital (France) Venture Capital

Milestone Pharmaceuticals Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Philippe Douville Ph.DFounder, Chief Executive Officer, Board Member & President
Jeff LeightonChief Scientific Advisor
Martin Maguire Ph.DVice President, Chemistry & Manufacturing
Douglas WightVice President, Drug Development
Guy Rousseau Ph.DVice President, Regulatory Affairs
Philippe Douville Ph.D Founder, Chief Executive Officer, Board Member & President
Jeff Leighton Chief Scientific Advisor
Martin Maguire Ph.D Vice President, Chemistry & Manufacturing
Douglas Wight Vice President, Drug Development
Guy Rousseau Ph.D Vice President, Regulatory Affairs

Milestone Pharmaceuticals Board Members (6)

NameRepresentingRoleSinceContact
Info
Debra LiebertDomain AssociatesManaging Director000 0000
Ela BorensteinBDC Healthcare Venture FundBoard Member000 0000
Paul TruexSelfChairman000 0000
Rodney Altman MDSelfBoard Member000 0000
Scott WeinerPappas VenturesPartner000 0000
Debra Liebert Managing Director Domain Associates
Ela Borenstein Board Member BDC Healthcare Venture Fund
Paul Truex Chairman Self
Rodney Altman MD Board Member Self
Scott Weiner Partner Pappas Ventures
Request full access to PitchBook